Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: Dallas TX, League City TX, Huntsville AL, Nashville TN,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT06962800

Phase3, Recruiting

Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

for
Left Atrial Appendage Closure
Location: Plano TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06348394

Recruiting

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

for
Breast Neoplasm
Location: Dallas TX, Greensboro NC, New York NY
Sponsor: Genta Incorporated

Sex: Female

Age: 18+

Code: NCT01221870

Phase2, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Dallas TX, Springfield MO, Kansas City MO, Columbia MO,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase2, Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Dallas TX, Houston TX, St Louis MO, Omaha NE, Denver CO,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

for
Breast Cancer, Breast Neoplasms, Breast Cancers
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT06517212

Phase2, Recruiting

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

for
Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT04265872

Early_phase1, Recruiting

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

for
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT06008275

Early_phase1, Recruiting

The Omeza Protocol for Chronic Ulcers

for
Venous Leg Ulcer, Diabetic Foot Ulcer
Location: Dallas TX, Jacksonville FL, Newark NJ, Portland OR
Sponsor: Omeza, LLC

Sex: All

Age: 21 - 70+

Code: NCT04198441

Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

for
HIV Infections
Location: Dallas TX, Kansas City MO, Atlanta GA, Tampa FL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07682961

Phase3, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Dallas TX, Tyler TX, Houston TX, Little Rock AR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase3, Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for
Acute Decompensated Heart Failure
Location: Dallas TX, Oklahoma City OK, Houston TX, Kansas City KS,
Sponsor: Reprieve Cardiovascular, Inc

Sex: All

Age: 22+

Code: NCT06898515

Phase3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Dallas TX, Tyler TX, San Antonio TX, Baton Rouge LA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

for
Acute Ischemic Stroke
Location: Dallas TX, Kansas City KS, St Louis MO, Chicago IL,
Sponsor: Amrou Sarraj

Sex: All

Age: 18 - 70+

Code: NCT07115940

Recruiting

UTSW NORC Pilot Spinal Cord Injury Dietary Program

for
Obesity and Obesity-related Medical Conditions,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT06924177

Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Location: Dallas TX, Houston TX, Atlanta GA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07222761

Phase3, Recruiting

Action Regulation Behavioral

for
Parkinson Disease
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06489483

Recruiting

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

for
Barrett Esophagus,
Location: Dallas TX, St Louis MO, Ann Arbor MI, Chapel Hill NC
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06732388

Phase2, Recruiting

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

for
Heart Failure, Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 0+

Code: NCT06593314

Recruiting

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for
AML, MDS
Location: Dallas TX, Austin TX, Houston TX, Aurora CO, Denver CO,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07702578

Phase3, Recruiting